Background
==========

Progression of microvascular complications in type 1 diabetic patients is influenced by arterial hypertension which is a well-recognized risk factor.[@b1-tcrm-11-1531] Type 1 diabetes mellitus (T1DM) is associated with an excess of cardiovascular disease; patients with diabetic nephropathy have a higher risk than those diabetic patients without kidney involvement.[@b2-tcrm-11-1531]

The diagnosis of hypertension is not an easy task, as one should follow measurement guidelines to decrease any avoidable mistakes thus giving accurate blood pressure (BP) readings.[@b3-tcrm-11-1531] In adults, to diagnose hypertension, measurements should be above the known normal levels. In children and adolescents, the task is more difficult as one should follow the percentile levels of BP of each age. Persistent readings of more than 95th percentile is considered hypertension in this age group.[@b4-tcrm-11-1531]

In patients with T1DM, especially the pediatric group, sporadic clinic BP measurement is not reliable. Measuring of BP over an extended period of time is more convenient and thus a highly valuable and effective tool.[@b5-tcrm-11-1531] Many studies have now confirmed that BP measured over a 24-hour period is superior to clinic BP measurement in predicting future cardiovascular events and target organ damage.[@b6-tcrm-11-1531],[@b7-tcrm-11-1531] To assess risk, whole daytime and nighttime ambulatory BP and BP load are used. The calculation of both systolic and diastolic load threshold is manually and automatically done. It is considered abnormal if BP loads are in excess of 25%--30%.[@b8-tcrm-11-1531]

BP will fall at night in normotensive individuals. People who undergo this normal physiological change are described as "dippers".[@b9-tcrm-11-1531] So if more than 10% of the diurnal BP values dropped nocturnally, it is considered a normal phenomenon. The non-dipping pattern is defined as a blunted decline in the person's physiological nocturnal BP drop in whom the BP remains high, ie, less than 10% lower than daytime average.[@b10-tcrm-11-1531]

Heart complications such as ventricular hypertrophy as well as renal insults with its events of microalbuminuria and decreased arterial acquiescence are developed in type 1 diabetic patients who display normal BP with non-dipping pattern; moreover, these patients represent a worse outcome.[@b11-tcrm-11-1531],[@b12-tcrm-11-1531]

Surprisingly, there are relatively few data to recognize whether the changes of BP through the day are represented in patients with diabetes mellitus as in the normal population.[@b13-tcrm-11-1531]

It is known that approximately one third of diabetic patients will suffer from renal insult an extended time after onset of diabetes. Clinically detectable diabetic nephropathy begins with the development of microalbuminuria.[@b14-tcrm-11-1531] Hypertension and microalbuminuria are considered the major cardiovascular risk factors in young patients with T1DM. Many studies have demonstrated that strict control of blood glucose level and BP significantly reduces the incidence and progression of diabetic kidney disease.[@b15-tcrm-11-1531]

Aim of study
------------

The present study was undertaken to characterize type 1 diabetic children and adolescents for detection of subtle BP abnormalities using ambulatory blood pressure monitoring (ABPM) and determining its relation to microalbuminuria and other diabetic parameters.

Methods and materials
=====================

The studied groups included 40 patients with T1DM. Their ages were from 8 to 17 years. All were diagnosed by decreased level of C-peptide (connecting peptide) with symptoms of diabetes; they were followed-up in pediatric clinic of Al Ansari Specialist Hospital. The studied group included 15 males and 25 females. Exclusion criteria were as follows: hypertensive patients, age above 18 years, receiving medication that affects BP or kidney such as angiotensin-converting-enzyme (ACE) inhibitors and other antihypertensive drugs, and other chronic illness regarding heart and kidneys. Inclusion criteria of diabetic group were children and adolescents aged below 18 years, diabetic patients diagnosed by glucose level, glycated hemoglobin (HBA~1c~), and C-peptide levels, normotensive by traditional simple sphygmomanometer method, and no history of medication such as antihypertensives or ACE inhibitors. Inclusion criteria of control group were children and adolescents aged below 18 years, normotensive by traditional simple sphygmomanometer method, no history of medication such as antihypertensives or ACE inhibitors, and no history of chronic illness such as diabetes, heart, or kidney diseases. The control group included 24 children (nine males, 15 females) of matched age and sex. They were randomly chosen from children attending outpatient clinics for general checkups and agreed to participate in this research. The study was approved by the local ethics committee, and informed consent was obtained from the parents or legal guardians of participating children and from children aged above 13 years.

All the studied groups were thoroughly evaluated. Full history-taking included duration of diabetes in years, dosage of insulin (units/kg of body weight) weight, height, and body mass index (BMI). Venous blood for testing HBA~1c~ levels was drawn from all study groups three times within at least 3 months interval, and the normal range was considered from 4.05% to 6.05% according to the Diabetes Control and Complication Trial. The test was done using COBAS INTE-GRA 400 (Hoffman-La Roche Ltd., Basel, Switzerland) for the quantitative determination of percent HBA~1c~ following manufacturer guidelines.

The International Society for Pediatric and Adolescent Diabetology defined persistent microalbuminuria as albumin excretion rate of 20--200 mg/min in timed overnight urine collection in two consecutive urine specimens 4 weeks apart. They also considered albumin/creatinine ratio of 30--300 mg/g in the morning spot urine sample as positive for microalbuminuria. In 24 hours urine collection; it is defined positive if albumin excretion rate is 30--300 mg/24 hours. In our study, we used albumin/creatinine ratio in the morning spot urine to study microalbuminuria in our studied groups. Microalbuminuria was determined from the collected three separate urine samples with at least 1 month interval. The patients were asked to avoid physical activity and had to be afebrile on the day of urine testing. Urinary albumin excretion was measured by the nephelometric method. BP profiles were compared with albumin/creatinine ratio.

Twenty-four hour ABPM
---------------------

ABPM was measured by an oscillometric monitor (Win Pro Model PG MAP; SunTech Medical Inc., Morrisville, NC, USA) that was validated for children. The monitor was attached to the nondominant arm using an appropriately sized cuff. The application of cuff around the arm should not be too tight or too loose; this was easily done by putting two fingers below the cuff area to ensure correct fit. The children were told that they may resume normal activities but instructed not to participate in strenuous activities or contact sports while wearing the monitor. They were asked to wear comfortable, loose shirts and a belt. The monitor was programmed to measure BP every 20 minutes during the day between 8 am and 10 pm and every 30 minutes during anticipated night sleep time (10 pm and 8 am). A reminder card was given to the volunteers to record their hours of sleep and when exactly they woke up, which was valuable when analyzing their BP values. Adhering to these instructions was a cornerstone for estimation of nocturnal dipping.[@b16-tcrm-11-1531] The ABPM recording was considered acceptable when a minimum of one reading per hour for a minimum of 20 hours (including six readings during sleep) was available. Mean daytime, mean nighttime, systolic BP, diastolic BP, and heart rate were calculated.

The night/day systolic BP and diastolic BP ratio was calculated for each patient and those with a ratio higher than 0.9 were classified as non-dippers.[@b17-tcrm-11-1531]

The nocturnal dip percentage is defined as more than 10% drop in systolic and diastolic readings and calculated as:[@b18-tcrm-11-1531] $$\frac{\text{Daytime~mean~BP} - \text{Nighttime~mean~BP}}{\text{Daytime~mean~BP}} \times 100$$

Ambulatory hypertension was considered to exist when the means of total daytime or nighttime systolic or diastolic BP were higher than expected for the 95th percentile of the subject's age, sex, and height, using standardized tables.[@b18-tcrm-11-1531]

We used *z*-score formula for BP parameters to normalize our data using the following equation: $$\text{z-score~value} = \frac{\text{Patient~BP~value} - \text{normal~BP~value~for~age~and~sex}}{\text{SD~of~normal~BP~value}}$$

In the studied groups, BP *z*-score \>0 means that systolic, diastolic, or mean BP is more than 95th percentile for sex, age, and height.

Statistical analysis
====================

Statistical analysis was performed using SPSS^®^ Statistics 20 (IBM Corporation, Armonk, NY, USA). After testing for Gaussian distribution (Kolmogrov--Smirnov), we found our data were nonparametric, and thus we used nonparametric test for comparisons between studied groups (Mann--Whitney). Multiple linear regression analysis was used to identify diabetes-associated risk factors for arterial hypertension. The independent variables which were used to compare with BP profiles were: age in years, total diabetes duration in years, sex, HBA~1c~ level, BMI, and the dosage of insulin in units/kg of weight. Statistical results were presented as mean ± standard deviation. In comparison tests, significance was defined by a *P*-value less than 0.05 and highly significant if less than 0.01.

Results
=======

Demographic, descriptive data including that of diabetes and BP profiles and their comparisons between patients and control groups were shown in [Table 1](#t1-tcrm-11-1531){ref-type="table"}. On comparing the data between the two sexes, we found that most of our study parameters with descriptive BP profiles did not differ between the two sexes ([Table 2](#t2-tcrm-11-1531){ref-type="table"}).

HBA~1c~, albumin/creatinine ratio, diabetes duration, and insulin dose were positively correlated with all BP parameters including systolic, diastolic, and mean (both nocturnal and diurnal); on the other hand, they were negatively correlated with nocturnal dipping of BP ([Table 3](#t3-tcrm-11-1531){ref-type="table"}).

Multiple regression analysis using age, sex, BMI, albumin/creatinine ratio, HBA~1c~, insulin dose, and diabetes duration as independent factors was performed ([Table 4](#t4-tcrm-11-1531){ref-type="table"}). It was found that systolic, diastolic, and mean arterial BP were significantly related to albumin/creatinine ratio, HBA~1c~, insulin dose, and BMI. Diabetes duration was significantly associated with increased night systolic BP.

Nocturnal dipping of BP was only associated with albumin/creatinine ratio ([Table 5](#t5-tcrm-11-1531){ref-type="table"}).

Discussion
==========

In this study, diabetic children showed abnormal BP profiles both systolic and diastolic with significant failure of nocturnal dipping.

Age-related changes in BP regulation were observed in diabetic patients suggesting accelerated vascular ageing.[@b19-tcrm-11-1531]

Being a diabetic patient, one is susceptible to cardiovascular complications and this risk increases significantly if one is pre-hypertensive with changes in ambulatory BP readings; this is evidenced in the Strong Heart Study.[@b20-tcrm-11-1531] Our study showed a similar conclusion as these "risky events" already began in children and adolescents who suffered from T1DM.

The increased night BP and occurrence of non-dipping is usually accompanied by cardiovascular insults in most patients.

This insult is an outcome of structural changes in arteries and their higher tone.[@b21-tcrm-11-1531] Major complications such as stroke and infarction of the heart easily occur in non-dippers if compared with normal dippers.[@b22-tcrm-11-1531]

The studied diabetic children and adolescents had abnormal BP regulation, especially during nighttime which means they may be facing many vascular complications even if they were only recently diagnosed as diabetics. The results regarding diabetic non-dipping during the night corresponds with results of Hermada et al.[@b23-tcrm-11-1531]

Markuszeuski et al studied the BP changes during 24 hours in T1DM patients. They demonstrated that both nocturnal systolic and diastolic BP were higher in diabetic patients than controls, and the absence of BP drop (non-dippers) was more prevalent in the diabetic group.[@b24-tcrm-11-1531] Their result corresponds with this study but disagree with regard to daytime BP, both systolic and diastolic. They found that daytime BP was not significantly different from the control group while this study's results demonstrated highly significant differences between both groups with regard to daytime systolic and diastolic BPs.

In this study, it was found that BMI was positively correlated with systolic BP both diurnal and nocturnal but had no effect on BP dipping. This result corresponded with that of Axel et al's findings.[@b25-tcrm-11-1531] Also, some researchers demonstrated a significant association between systolic BP and BMI.[@b18-tcrm-11-1531]

The insulin need is usually increased due to insulin resistance which occurs in obese subjects with a high BMI.[@b26-tcrm-11-1531] Uncontrolled diabetic condition for an extended period of time eventually causes vascular disturbances and endothelial damage that can easily lead to changes in BP values and difficulty in its regulation.[@b27-tcrm-11-1531]

These findings support this research result that poor glycemic control reflected by elevated HBA~1c~ was significantly associated with elevated systolic and diastolic BP both diurnal and nocturnal. In contrast, some research failed to find any correlation between HBA~1c~ and hypertension in diabetic children.[@b15-tcrm-11-1531]

No relation between sex and alterations of BP was demonstrated, unlike Axel et al[@b25-tcrm-11-1531] who found that BP changes are more prevalent in female patients and explained their findings by the fact that females tend to be obese during puberty with subsequent increase of insulin resistance, thus causing such alterations.

Our research results could be explained by the fact that both groups of males and females in study groups were not different with regard to BMI and HBA~1c~, so the effect of hyperinsulinemia and hyperglycemia did not appear obviously between the studied patients (both females and males), and may be due to the small sample size of this study.

Many studies showed that diabetic children mostly have diabetic renal insult which occurred due to microalbuminuria as a result of both impaired nighttime BP and uncontrolled diabetic condition.[@b12-tcrm-11-1531],[@b28-tcrm-11-1531] In accordance, this study data suggested that all BP profiles whether systolic or diastolic both nocturnal and diurnal were highly positively correlated with microalbuminuria. Moreover, microalbuminuria was more frequently linked to non-dippers than dippers in the diabetic group. Many investigators also revealed that diabetic children with hypertension were significantly associated with microalbuminuria.[@b29-tcrm-11-1531],[@b30-tcrm-11-1531] This relation is denied by other researchers who stated that there was no correlation between hypertension and microalbuminuria in diabetic children.[@b15-tcrm-11-1531] It is speculated that in diabetic patients, the tone of sympathetic nervous system is increased including renal vessels and consequently resulting in diminishing both glomerular filtration rate and sodium excretion, causing albuminuria and progressive renal damage. Thus, non-dipping phenomenon resulting from higher sympathetic tone is connected to diabetic nephropathy.[@b31-tcrm-11-1531]

Age and diabetes duration were also correlated to changes in BP. They are non-modifiable risk factors and they can be used as a tool to classify patients at a higher risk for arterial hypertension who require special monitoring. On the other hand, metabolic state, BMI, and insulin dose are considered modifiable risk factors that need to be optimized for effective BP control during the day.

Recommendations
===============

1.  The rapid proper diagnosis of hypertension in diabetic children using ABPM is often a "wake-up call", and following-up those patients is an opportunity to make lifelong changes that will likely decrease their risk of developing chronic complications and enable vascular directed preventive intervention at the earliest possible time.

2.  Further work is required to see if the BP load could be one of the predictive parameters in ABPM in normotensive T1DM children. While using 24-hour ambulatory BP in this study, systolic BP load had been observed to be higher than 40% in most of the diabetic patients which is considered, in hypertensive adult patients, an early prognostic marker for cardiovascular events.

Many thanks to Mr Amer, the medical technician who helped a lot with regard to ABPM device fixation and calibration for proper analysis.
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###### 

Descriptive data and comparison study between studied groups using Mann--Whitney test

  --------------------------------------------------------------------------------------------------------------
  Parameters                                     Patients\   Controls\   *P* (significance)           
                                                 (n=40)      (n=24)                                   
  ---------------------------------------------- ----------- ----------- -------------------- ------- ----------
  Age in years                                   11.56       2.82        13.5                 2.96    0.067

  Height *z*-score                               1.41        12.92       1.54                 14.37   0.014

  BMI                                            19.40       3.04        19.36                1.97    0.761

  IDDM duration in years                         4.64        2.70        0.0                  0.0     \<0.0001

  HBA~1c~                                        11.22       1.70        5.00                 0.0     \<0.0001

  Insulin dose units/kg BW                       0.99        0.27        0.0                  0.0     \<0.0001

  Albumin/creatinine ratio                       42.34       8.673       16.83                3.12    \<0.0001

  Daytime systolic blood pressure *z*-score      7.73        1.62        0.0                  0.0     \<0.0001

  Nighttime systolic blood pressure *z*-score    8.73        0.78        0.0                  0.0     \<0.0001

  Daytime diastolic blood pressure *z*-score     5.80        0.38        0.0                  0.0     \<0.0001

  Nighttime diastolic blood pressure *z*-score   9.50        1.95        0.0                  0.0     \<0.0001

  Mean daytime blood pressure *z*-score          5.22        0.79        0.0                  0.0     \<0.0001

  Mean nighttime blood pressure *z*-score        6.98        0.67        0.0                  0.0     \<0.0001

  Nocturnal systolic dipping                     7.80        4.85        16.12                3.00    \<0.0001

  Nocturnal diastolic dipping                    7.68        4.91        22.46                3.17    \<0.0001
  --------------------------------------------------------------------------------------------------------------

**Abbreviations:** BMI, body mass index; IDDM, insulin dependent diabetes mellitus; HBA~1c~, glycated hemoglobin; BW, body weight.

###### 

Comparison study between males and females in the study group by Mann--Whitney test

  Parameters                                     *P* (significance)
  ---------------------------------------------- --------------------
  Age                                            0.308
  Height                                         0.199
  BMI                                            0.685
  IDDM duration in years                         0.845
  HBA~1c~                                        0.408
  Insulin dose units/kg BW                       0.775
  Albumin/creatinine ratio                       0.685
  Daytime systolic blood pressure *z*-score      0.663
  Nighttime systolic blood pressure *z*-score    0.822
  Daytime diastolic blood pressure *z*-score     0.822
  Nighttime diastolic blood pressure *z*-score   0.663
  Mean daytime blood pressure *z*-score          0.641
  Mean nighttime blood pressure *z*-score        0.641
  Nocturnal systolic dipping                     0.916
  Nocturnal diastolic dipping                    0.443

**Abbreviations:** BMI, body mass index; IDDM, insulin dependent diabetes mellitus; HBA~1c~, glycated hemoglobin; BW, body weight.

###### 

Correlation study between blood pressure parameters and studied variables using Spearman test

  Variables                  Daytime systolic blood pressure *z*-score   Nighttime systolic blood pressure *z*-score             Daytime diastolic blood pressure *z*-score   Nighttime diastolic blood pressure *z*-score            Mean daytime *z*-score   Mean nighttime *z*-score                                Nocturnal systolic dipping   Nocturnal diastolic dipping                                                                                                                                                                                                                                         
  -------------------------- ------------------------------------------- ------------------------------------------------------- -------------------------------------------- ------------------------------------------------------- ------------------------ ------------------------------------------------------- ---------------------------- ------------------------------------------------------- -------- ------------------------------------------------------- -------- ------------------------------------------------------- -------- ------------------------------------------------------- -------- -------------------------------------------------------
  Height                     0.052                                       0.762                                                   −0.305                                       0.067                                                   −0.205                   0.225                                                   −0.186                       0.271                                                   −0.198   0.240                                                   −0.418   0.010[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}      0.210    0.211                                                   0.149    0.378
  BMI                        0.126                                       0.457                                                   0.249                                        0.137                                                   0.150                    0.375                                                   −0.270                       0.105                                                   −0.195   0.247                                                   −0.074   0.662                                                   0.075    0.660                                                   0.306    0.065
  IDDM duration              0.961                                       \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.652                                        \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.668                    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.858                        \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.853    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.728    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   −0.622   \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   −0.823   −0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}
  HBA~1c~                    0.732                                       \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.694                                        \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.656                    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.793                        \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.821    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.631    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   −0.514   0.001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}      −0.711   \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}
  Insulin dose               0.788                                       \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.748                                        \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.805                    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.754                        \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.753    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.542    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   −0.390   0.017[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}      −0.726   \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}
  Albumin/creatinine ratio   0.776                                       \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.594                                        \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.643                    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.0841                       \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.800    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   0.656    \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   −0.590   \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}   −0.854   \<0.0001[\*](#tfn4-tcrm-11-1531){ref-type="table-fn"}

**Notes:** *r*, Spearman correlation;

*P*\<0.05 (statistically significant).

**Abbreviations:** BMI, body mass index; IDDM, insulin dependent diabetes mellitus; HBA~1c~, glycated hemoglobin.

###### 

Multiple linear regression analysis for blood pressure parameters

  Parameters                  SBP      DBP                                                     MAP                                                                       
  --------------------------- -------- ------------------------------------------------------- -------- ------------------------------------------------------- -------- -------------------------------------------------------
  Day                                                                                                                                                                    
   Age                        −2.129   0.042[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      −1.557   0.131                                                   −4.118   \<0.0001[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}
   Sex                        0.067    0.947                                                   1.595    0.122                                                   0.817    0.421
   IDDM duration in years     1.956    0.061                                                   −3.325   0.002[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      0.642    0.526
   HBA~1c~                    2.231    0.034[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.148    0.041[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.302    0.029[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}
   Insulin dose               5.444    \<0.0001[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}   5.149    \<0.0001[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}   2.700    0.012[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}
   BMI                        3.193    0.003[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.977    0.006[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.271    0.031[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}
   Albumin/creatinine ratio   3.950    \<0.0001[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}   2.993    0.006[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.810    0.009[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}
  Night                                                                                                                                                                  
   Age                        −4.050   \<0.0001[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}   −2.407   0.023[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      −1.895   0.069
   Sex                        0.897    0.378                                                   0.828    0.414                                                   1.891    0.069
   IDDM duration              −3.399   0.002[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      0.920    0.366                                                   −1.544   0.134
   HBA~1c~                    2.886    0.007[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.225    0.034[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      1.609    0.119
   Insulin dose               6.048    \<0.0001[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}   2.473    0.020[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.734    0.011[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}
   BMI                        5.016    \<0.0001[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}   −0.984   0.333                                                   1.960    0.060
   Albumin/creatinine ratio   2.898    0.007[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.836    0.008[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}      2.624    0.014[\*](#tfn6-tcrm-11-1531){ref-type="table-fn"}

**Note:**

*P*\<0.05 (statistically significant).

**Abbreviations:** BMI, body mass index; IDDM, insulin dependent diabetes mellitus; HBA~1c~, glycated hemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure.

###### 

Multiple linear regression analysis for nocturnal dipping

  Parameters                 Systolic blood pressure   Diastolic blood pressure                             Mean blood pressure                                                                 
  -------------------------- ------------------------- ---------------------------------------------------- --------------------- ---------------------------------------------------- -------- ----------------------------------------------------
  Age                        −1.560                    0.130                                                0.844                 0.406                                                0.046    0.0963
  Sex                        0.880                     0.372                                                −0.356                0.725                                                0.031    0.975
  IDDM duration              1.966                     0.07                                                 1.141                 0.264                                                −1.108   0.277
  HBA~1c~                    1.611                     0.120                                                −0.917                0.367                                                −1.216   0.234
  Insulin dose               0.830                     0.416                                                0.891                 0.380                                                0.606    0.549
  BMI                        0.067                     0.947                                                1.209                 0.237                                                1.560    0.130
  Albumin/creatinine ratio   2.897                     0.007[\*](#tfn8-tcrm-11-1531){ref-type="table-fn"}   2.303                 0.029[\*](#tfn8-tcrm-11-1531){ref-type="table-fn"}   2.989    0.005[\*](#tfn8-tcrm-11-1531){ref-type="table-fn"}

**Note:**

*P*\<0.05 (statistically significant).

**Abbreviations:** BMI, body mass index; IDDM, insulin dependent diabetes mellitus; HBA~1c~, glycated hemoglobin.
